According to the findings of accelerated maturation of limbic regions as a consequence of LBN and MS, it is reasonable to hypothesize a targeted increase of BDNF and IGF-1 in the cortico-limbic pathway. The gene discussed is BDNF; the disease is myeloid sarcoma.